Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,903
Closed -$259K 1106
2025
Q4
$259K Sell
1,903
-2,113
-53% -$304K 0.01% 638
2025
Q3
$592K Buy
4,016
+557
+16% +$77.3K 0.02% 457
2025
Q2
$447K Sell
3,459
-136
-4% -$16.5K 0.02% 438
2025
Q1
$429K Buy
+3,595
New +$446K 0.02% 406

Other funds holding XYL

VestGen Advisors's XYL Position: Q1 2026 in Review

VestGen Advisors sold out of Xylem (XYL) in Q1 2026, closing a stake of 1,903 shares — an estimated $259K sold.

VestGen Advisors first reported a position in XYL in Q1 2025 and held it in 4 quarters. The position peaked at $592K in Q3 2025. 1,111 funds tracked by Wall St. Rank hold XYL as of Q1 2026.

  • VestGen Advisors reported no remaining Xylem position as of Q1 2026 after selling out during the quarter.
  • VestGen Advisors sold 1,903 Xylem shares in Q1 2026, an estimated $259K.
  • VestGen Advisors first reported a position in Xylem in Q1 2025 and held it in 4 quarters.
  • VestGen Advisors's Xylem position peaked at $592K in Q3 2025.
  • 1,111 funds tracked by Wall St. Rank held Xylem as of Q1 2026.

Based on VestGen Advisors's 13F filing for Q1 2026, filed 14 May 2026.